JPS6025985A - Preparation of piperazine derivative - Google Patents

Preparation of piperazine derivative

Info

Publication number
JPS6025985A
JPS6025985A JP58133398A JP13339883A JPS6025985A JP S6025985 A JPS6025985 A JP S6025985A JP 58133398 A JP58133398 A JP 58133398A JP 13339883 A JP13339883 A JP 13339883A JP S6025985 A JPS6025985 A JP S6025985A
Authority
JP
Japan
Prior art keywords
group
formula
compound shown
reactive derivative
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP58133398A
Other languages
Japanese (ja)
Inventor
Kazuo Ohira
一夫 大平
Shiyouzou Nakaoku
中奥 省三
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiyo Pharmaceutical Industry Co Ltd
Original Assignee
Taiyo Pharmaceutical Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiyo Pharmaceutical Industry Co Ltd filed Critical Taiyo Pharmaceutical Industry Co Ltd
Priority to JP58133398A priority Critical patent/JPS6025985A/en
Publication of JPS6025985A publication Critical patent/JPS6025985A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:To obtain the titled compound useful as a drug having high antiemetic action and antispasmodic action extremely in high purity, by reacting a piperazine derivative with benzhydrol. CONSTITUTION:A compound shown by the formula I (X is halogen; l and m are 1-4) or its reactive derivative at its hydroxyl group is reacted with a compound shown by the formula II(Y and Z are H, halogen, lower alkyl, lower alkoxy, trifluoromethyl, nitro, or methyleneoxy) or its reactive derivative at its hydroxyl group in a solvent such as toluene, ethylbenzene, etc. in the presence of a strong base (e.g., sodium amide, sodium hydride, metal sodium, etc.) under heating to give the desired compound shown by the formula III. Either of the compound shown by the formula I and the compound shown by the formula II is preferably used in the form of the reactive derivative, especially halide.

Description

【発明の詳細な説明】 本発すJ i−1:次の一般式(1) (1) (但シ、Xはハロゲン原子を、Yおよび2は水素原子、
ハロゲン原子、低級アルキル基、低級アルコキシ基、ト
リフルオロメチル基、ニトロ基苔たはメチレジオキシ基
を、tおよびmは1から4の整数を表わす7) で示されるピペラジン誘導体又(はその塩の衝規な製造
法に関する。
Detailed Description of the Invention J i-1 produced by the present invention: the following general formula (1) (1) (where X is a halogen atom, Y and 2 are hydrogen atoms,
A halogen atom, a lower alkyl group, a lower alkoxy group, a trifluoromethyl group, a nitro group or a methyledioxy group, and t and m are integers from 1 to 4. Regarding standard manufacturing methods.

一般式CI)のピペラジン誘導体、就中特に1−〔2−
(4−メトキシベンズヒドリルオキシ)エチル)−4−
43−(4−フルオロペノゾイル)プロピルコピペラジ
ン・シマレイト等は、強力な制吐作用および鎮痙作用を
示し、人間や動物の疾病に対する治療薬として極めて優
れた効力を有することか知られている(西独公開特許公
報第2.719,246号)、。
Piperazine derivatives of the general formula CI), especially 1-[2-
(4-methoxybenzhydryloxy)ethyl)-4-
43-(4-fluoropenozoyl)propylcopiperazine cimarate and the like are known to exhibit strong antiemetic and antispasmodic effects, and to have extremely excellent efficacy as therapeutic agents for diseases in humans and animals. West German Published Patent Application No. 2.719,246).

従来、これらの化合物を製造する方法としては、例工ば
、γ−クロローバラーフルオロプチロフエノノとl−パ
ラーメトキシベノズヒドリルオキシエチルビペラジンを
ヨウ化ナトリウム及び重曹の存在下反応させる方法が知
られている(西独公開特許公報第2719.246号)
1、 しかしながら、この方法では、目的物、例えば1−[2
−(4−メトキシベノズヒドリルオキシノエチル)−4
−[3−(4−フルオロベノゾイル)プロピルコピペラ
ジン・シマレイト中に出発物質である1−パラーメトキ
シベンズヒドリルオキシエチルピペラジン及び他の不純
物を多量に含み(第1図参照)、しかもこれらの不純物
は再結晶等の精製操作でも除去することは困難であるた
め、どうしても製品中に混入することを免れず、医薬品
を得るだめの方法としては不適当であったーそこで、本
発明者ハ(1)式の化合物を高純度で得る方法を提供す
べく種々研究を行った結果、本発明を完成した。
Conventionally, methods for producing these compounds include, for example, reacting γ-chlorovaler fluoroptylophenono and l-paramethoxybenozhydryloxyethylbiperazine in the presence of sodium iodide and sodium bicarbonate. A method is known (West German Published Patent Application No. 2719.246)
1. However, in this method, the target object, e.g. 1-[2
-(4-methoxybenozhydryloxynoethyl)-4
-[3-(4-fluorobenozoyl)propylcopiperazine simalate contains a large amount of the starting material 1-paramethoxybenzhydryloxyethylpiperazine and other impurities (see Figure 1), and these Since impurities are difficult to remove even through purification operations such as recrystallization, they inevitably get mixed into the product, making it unsuitable as a method for obtaining pharmaceuticals. The present invention has been completed as a result of various studies aimed at providing a method for obtaining the compound of formula 1) with high purity.

本発明方法は次の反応式によって示される。The method of the present invention is shown by the following reaction formula.

(n) Cm) (、V) (但し、Wはハロゲノ原子を表わし、他の符号は前記と
11」」じ意味を有する) すなわち、不発[!Ijは、アルキルフェノ7(II)
にピペラジノアルカノール(III)を反応せしめて(
■)式の化合物となし、次いでこの生成物i ′7c(
tJ、そのヒドロキシ基における反応性誘導体にベンズ
ヒドロール(V)丑たはヒドロキシ基における反IL;
11d等体を反応せしめてピペラジン肋4体(1)tW
造する方法である。
(n) Cm) (,V) (However, W represents a halide atom, and the other symbols have the same meanings as above.) In other words, a non-explosion [! Ij is alkylphenol 7(II)
was reacted with piperazinoalkanol (III) (
■) compound of formula and then this product i '7c (
tJ, a reactive derivative of benzhydrol (V) in its hydroxy group or anti-IL in its hydroxy group;
Reacting the 11d isomer to produce 4 piperazine ribs (1) tW
It is a method of building.

化合物(II)及び(■)から化合物(IV)全得るに
は、(II)と(川)を適当な溶媒中、脱酸剤の存在下
加熱還流ラーれによい。溶媒としては、両者を溶解し、
反応に悪影響を与えないものであれはよく、例えばメタ
ノール、エタノール、プロパツール等のアルコール系溶
媒、アセトン、べ/ゼン靜が埜げられ、なた脱酸剤とし
ては、例えば炭酸水垢ナトリウム、炭酸水素カリウム、
炭n2ナトリウム、炭酸カリウム等が使用される。
In order to obtain all of Compound (IV) from Compounds (II) and (■), (II) and (II) may be heated under reflux in a suitable solvent in the presence of an acid-reducing agent. As a solvent, dissolve both,
Anything that does not adversely affect the reaction may be used, such as alcoholic solvents such as methanol, ethanol, and propatool, acetone, and alcoholic solvents. Examples of deoxidizing agents include sodium carbonate and carbonic acid. potassium hydrogen,
Carbon n2 sodium, potassium carbonate, etc. are used.

斯くして得らh−る(IV)式の化合物は、そのj:寸
CV)式の化合物との反応Vこ供し;HJるが、(IV
)又は(V)の何れか一方を反応性誘導体の形で用いる
のが好ましい。これらのヒドロキシ基における反応性誘
導体としてはハライド、トシルエステル静か挙げられる
が、特にハライドが好貰しい、(IV)と(V)の反応
は、両者を適当な溶媒中、強塩基の存在下加湿すればよ
い。溶媒としては両者を溶方「1し、反応を阻害しない
ものでろiLばよく、例えばトルエン、エチルベンゼノ
、キシレン等が挙ケられ、また強塩基としては、例えば
ナトリウムアミド、ナトリウムハイドライド、金属ナト
リウム等が使用さノLる。
The compound of formula (IV) thus obtained is subjected to a reaction with a compound of formula (CV);
) or (V) is preferably used in the form of a reactive derivative. Reactive derivatives of these hydroxy groups include halides and tosyl esters, with halides being particularly preferred.The reaction between (IV) and (V) is carried out by humidifying both in an appropriate solvent in the presence of a strong base. do it. The solvent should be one that dissolves the two and does not inhibit the reaction, such as toluene, ethylbenzene, xylene, etc., and strong bases such as sodium amide, sodium hydride, metallic sodium, etc. is used.

このようにして得られる(1)式の化合物は極めて高純
度で必シ(第1図参照)、従来法のような不純物はほと
んど含まれていない。これは常法によって塩とすること
ができ、塩としてはマレイン酸、フマール酸等の有機塩
が好ましい。
The compound of formula (1) obtained in this way has extremely high purity (see Figure 1), and contains almost no impurities unlike conventional methods. This can be converted into a salt by a conventional method, and the salt is preferably an organic salt such as maleic acid or fumaric acid.

次に実施例、比較例及び試験例を誉げて説明する。Next, Examples, Comparative Examples, and Test Examples will be explained.

実施例1 1− (’ 2− (4−メトキシベンズヒドリルオキ
シ)エチル)−4−[3−(4−フルオロベンゾイル)
プロピルコピペラジン・シマ)/イトの製造 (1)1−(2−ヒトr?キシルエチル)−4−〔3−
(4−フルオロベンゾイル)プロピルコピペラジンの製
造; γ−クロローp−フルオロブチロフェノン23.2y、
1〜ピペラジノエタノール:1.5.1 !i’及び炭
酸水素カリウム1467を含むエタノール100m7!
の溶液を、−夜拮拌下還流した。放冷後、不溶物を沖過
LF!を減圧下治縮した。残渣を希塩酸に溶カ′lニジ
クロロホルム洗浄後、希水鼠化ナトリウム溶液にてアル
カリとし酢酸エチルにて抽出した8水洗後、芒硝乾燥し
溶媒を減圧留去した。残渣は、ペンゼノーリグロイノよ
シ肖結晶し、1−(2−ヒドロキシエチル)−4−[3
−(11−フル垢ロベ/ゾイル)ソロビルコピペラジノ
2!j、6f(収率87チ)を得た。
Example 1 1-('2-(4-methoxybenzhydryloxy)ethyl)-4-[3-(4-fluorobenzoyl)
Production of propylcopiperazine (sima)/ite (1) 1-(2-human r?xylethyl)-4-[3-
Production of (4-fluorobenzoyl)propylcopiperazine; γ-chlorop-fluorobutyrophenone 23.2y,
1~Piperazinoethanol: 1.5.1! 100 m7 of ethanol containing i' and 1467 potassium bicarbonate!
The solution was refluxed overnight with stirring. After cooling, insoluble matter is passed through LF! was contracted under reduced pressure. The residue was dissolved in dilute hydrochloric acid, washed with dichloroform, made alkaline with dilute sodium chloride solution, extracted with ethyl acetate, washed with 8 waters, dried with sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was crystallized as 1-(2-hydroxyethyl)-4-[3
-(11-Furuko Robe/Zoil) Solo Bilko Piperazino 2! j, 6f (yield: 87 h) were obtained.

融点 96〜975℃ 11も; シcm−’ 3400+29 40.282
0.1+j75゜1590.1218,1150,10
50゜1ooo、 sa、。
Melting point 96-975℃ 11 too; cm-' 3400+29 40.282
0.1+j75°1590.1218,1150,10
50゜1ooo, sa.

(2) 1’7 (2−クロロエチル)−4−43−(
4−フルオロベンゾイル)プロピルコピペラジンの製造 塩化チオニル8−を水塩にて冷却し、1−(2−ヒドロ
キシエチル)−4−43−(4−フルオロベンゾイル)
プロピルコピペラジン12を徐々に加えfC9添加後、
室温にて4時間攪拌した後、塩化チオニルを減圧留去し
た。残液に水を加え、希水酸化ナトリウムでアルカリと
した後1】−ヘキサンで抽出した。水洗後、芒硝乾燥し
溶媒を減圧留去し、1−(2−クロロエチル)−4−4
3−(4−フルオロベンゾイル)プロピル〕ピペラジ7
900 m’j (収率85%)を得た。
(2) 1'7 (2-chloroethyl)-4-43-(
Production of 4-fluorobenzoyl)propylcopiperazine Thionyl chloride 8- was cooled with aqueous salt to produce 1-(2-hydroxyethyl)-4-43-(4-fluorobenzoyl).
After gradually adding propylcopiperazine 12 and adding fC9,
After stirring at room temperature for 4 hours, thionyl chloride was distilled off under reduced pressure. Water was added to the residual liquid, made alkaline with dilute sodium hydroxide, and then extracted with 1]-hexane. After washing with water, drying the sodium sulfate and removing the solvent under reduced pressure, 1-(2-chloroethyl)-4-4
3-(4-fluorobenzoyl)propyl]piperazi 7
900 m'j (yield 85%) was obtained.

融点 38〜39℃ I R;シcJrt−’ 2940.2810,167
0.1590゜1228.1153,1000,850
゜15 (3) 1.− [2−(4−メトキシベンズヒドリル
オキシ)エチル]−4−43−(4−フルオロベンゾイ
ル)ブ[1ピル〕ピペラジン・シマレイトの製造; ;無zkl−ルエン5 nrAにナトリウムアミド67
mgをb’l蜀させ、次いで久1天水トルエン2.5 
mlにf答辞した4−メト片シベ/ズヒドロール350
 T4をゆつくシ加えた後、1時間還流した。放冷後、
無水トルエン2.5 meに溶解した1−(2−クロロ
エチル)−4−43−(4−フルオロベンゾイル)プロ
ピル]ピペラジンb1o+ns+@加え、さらに3時間
還流した。放冷後、水を加えトルエン層を分取した。さ
らにベンゼンで抽出し41機層を合せ一芒硝乾燥後、減
圧下θ縮し/で8残渣をシリカゲルカラムクロマド〔展
開。′靜婬アセトン:クロロホルム=I:2)Qこて鞘
製し1−(2−(4−メトキシベンズヒドリルオキシ)
エチル) −4,−C50−(4−フルオロベンゾイル
)プロピルコピペラジノ670y+C収率83、係)を
得た。
Melting point 38-39°C IR; cJrt-' 2940.2810,167
0.1590°1228.1153,1000,850
゜15 (3) 1. - Preparation of [2-(4-methoxybenzhydryloxy)ethyl]-4-43-(4-fluorobenzoyl)but[1-pyl]piperazine cimarate; ; no zkl-luene 5 nrA with sodium amide 67
mg to b'l Shu, then Ku1 Tensui Toluene 2.5
4-Methochloride/Zuhydrol 350 in response to ml
After slowly adding T4, the mixture was refluxed for 1 hour. After cooling,
1-(2-chloroethyl)-4-43-(4-fluorobenzoyl)propyl]piperazine b1o+ns+@ dissolved in 2.5 me of anhydrous toluene was added, and the mixture was further refluxed for 3 hours. After cooling, water was added and the toluene layer was separated. Further, extract with benzene, combine the 41 layers, dry with a sniper salt, condense under reduced pressure, and develop the 8 residue with a silica gel column chromatography. 'Jingyu Acetone:Chloroform=I:2) Q trowel sheathed 1-(2-(4-methoxybenzhydryloxy)
ethyl)-4,-C50-(4-fluorobenzoyl)propylcopiperazino 670y+C yield: 83, yield).

油状物 ■几ニジcm” 2925,2800,1678,15
90゜1500.1240I 830 上記で得た1−(2−(4−メトキシベンズヒドリルオ
キシ)エチル)−4−(’3−(4−フルオロベンゾイ
ル)プロピルコピペラジン6707ngをメタノール1
0mAに溶解し、メタノール5mlに溶解したマレイン
酸350mfを加え、析出する結晶をP取した。メタノ
ール洗浄後、乾燥させ1−、C2−(4−メトキシベン
ズヒドリルオキシ)エチル〕−#−C3−C4−フルオ
ロベンゾイル)プロピルコピペラジン・シマレイト90
0 yn!(収率91%)を得た。
Oily substance 2925, 2800, 1678, 15
90゜1500.1240I 830 6707 ng of 1-(2-(4-methoxybenzhydryloxy)ethyl)-4-('3-(4-fluorobenzoyl)propylcopiperazine) obtained above was dissolved in methanol 1
350 mf of maleic acid dissolved in 0 mA and 5 ml of methanol was added, and the precipitated crystals were collected. After washing with methanol and drying, 1-,C2-(4-methoxybenzhydryloxy)ethyl]-#-C3-C4-fluorobenzoyl)propylcopiperazine simalate 90
0yn! (yield 91%).

融点 159〜161℃ IIもニジcrrr−’ 3500〜3350.275
0〜2100゜1688.1570,1510,146
0゜1360.1250,1100.870比較例 (i)1− c 2− (4−メトキシベンズヒドリル
オキシ)エチルコピペラジン: 無水ピペラジン67とトルエ、227n1.の混合物を
遠流し、これにトルエン8meK1−CC4−メトキン
ベンズヒドリル)オキシフ−2−クロロエタン4.82
を溶解したものをゆつく9滴下する。次いで15時間還
流した後、70℃伺近まで冷却(2水を加え、水洗(2
回)する。10%酢酸で抽出し、トルエンで洗浄後、希
水酸化ナトリウムでアルカリ性とし、トルエンで抽出す
る。水洗後、芒硝にて乾燥し、トルエンを減圧留去し油
状物の標記化合物4.84f!を得る。
Melting point 159-161℃ II also rainbow crrr-' 3500-3350.275
0~2100°1688.1570,1510,146
0°1360.1250, 1100.870 Comparative Example (i) 1-c2-(4-methoxybenzhydryloxy)ethylcopiperazine: Anhydrous piperazine 67 and toluene, 227n1. A mixture of toluene, 8meK1-CC4-methquine, benzhydryl)oxyph-2-chloroethane, and 4.82
Slowly add 9 drops of the dissolved solution. Then, after refluxing for 15 hours, cooling to around 70°C (2 times, adding water and washing with water (2 times)
times). Extract with 10% acetic acid, wash with toluene, make alkaline with dilute sodium hydroxide, and extract with toluene. After washing with water, drying with Glauber's salt and distilling off the toluene under reduced pressure, the title compound of oily substance 4.84f! get.

(ii)1−[2−(4−メトキンベンス°ヒドリルオ
キシ〕エチル)−4−(3,−(4−フルオロベンゾイ
ル)プロピル〕ビペラノン・シマレイト: 1− [2((4−メトキシベンズヒドリル〕オキシ〕
エチル〕ピペラジ747、γ−クロローp−フルオロブ
チロフェノン27g、炭酸水素ナトリウム19g′、ヨ
ウ化カリウム0132及びメチルエチルケトン401r
rlの混合物ヲ]616時間還流。放冷汲水を加え、有
様層葡分取する。さらに水層をメチルエチルケトノで抽
出し、有機層を合ぜ芒硝乾燥後、溶媒を減圧留去し油状
物5.22を得る。
(ii) 1-[2-(4-methoxybenzhydryloxy]ethyl)-4-(3,-(4-fluorobenzoyl)propyl]biperanone cimarate: 1-[2((4-methoxybenzhydryl)oxy) ]
ethyl]piperazi 747, γ-chlorop-fluorobutyrophenone 27g, sodium bicarbonate 19g', potassium iodide 0132 and methyl ethyl ketone 401r
Reflux the mixture of RL for 616 hours. Add cooled water and separate the layers. Further, the aqueous layer was extracted with methyl ethyl ketone, the organic layers were combined and dried with mirabilite, and the solvent was distilled off under reduced pressure to obtain an oily substance 5.22.

得られた油状物をメタノールbO−に溶解し、マレイン
酸32をメタノール20 miに溶解したものを加え、
析出する結晶を枦取する。これをメタノールで洗浄後、
減圧下乾燥し、標記化合物6.67を得る。
The obtained oil was dissolved in methanol bO-, and a solution of 32 m of maleic acid in 20 mi of methanol was added.
Collect the precipitated crystals. After washing this with methanol,
Drying under reduced pressure yields the title compound 6.67.

試検例 1−(2−(4−メトキシベンス゛ヒドリルオキシ)エ
チル、]−4[3= [4−フルオロベノゾイル〕プロ
ピル〕ピペラジン塩基(図中−1)、マレイン酸(図中
−2)、実施例3で得らり、た生成物(図中−3)及び
比較例(11)で得られた生成物(図中−4)の各10
りをメタノール5 tJに浴かし、この溶液100μt
を薄層板にスポットし、次の条件で薄層クロマトグラフ
ィー・を行った。
Trial test example 1 - (2-(4-methoxybenzhydryloxy)ethyl,]-4[3=[4-fluorobenozoyl]propyl]piperazine base (-1 in the figure), maleic acid (-2 in the figure) ), 10 each of the product obtained in Example 3 (-3 in the figure) and the product obtained in Comparative Example (11) (-4 in the figure)
of this solution in 5 tJ of methanol.
was spotted on a thin layer plate, and thin layer chromatography was performed under the following conditions.

展開溶媒:イソプロパノ−ルー酢酸エチル−水−アンモ
ニア水(3:1:1:1) 薄層板:キーゼルゲル6011’ 254厚さ0.2 
Mn(メルク社’A ) 201m X 20 r1n
展開距¥11;約10 cm 検出方法:紫外線照射(主波長245 +1210その
結果は第1図のと:16りであり、これから従来法(比
較例)でイ(tられるものは種々の不純物を含有するが
、本発明で得られるものは不純物を含んでいないことが
判4)。
Developing solvent: Isopropanol-ethyl acetate-water-ammonia water (3:1:1:1) Thin layer plate: Kieselgel 6011' 254 thickness 0.2
Mn (Merck & Co. 'A) 201m x 20 r1n
Deployment distance ¥11; approx. 10 cm Detection method: Ultraviolet irradiation (main wavelength 245 + 1210) The results are as shown in Figure 1: However, it was found that the product obtained by the present invention does not contain impurities.4)

【図面の簡単な説明】[Brief explanation of drawings]

第1図は、本発明方法及び従来法て得た生成物の薄層ク
ロマトグラムでわる。 IJi“余白
FIG. 1 shows thin layer chromatograms of the products obtained by the method of the present invention and the conventional method. IJi “margin”

Claims (2)

【特許請求の範囲】[Claims] (1)一般式 (但し、Xはハロゲン原子を、tおよびmは1から4の
整数を表わす) で示される化合物またはそのヒドロキシ基における反応
性誘導体に一般式 (但し、YおよびZは水素原子、ハロゲン原子、低級ア
ルキル基、低級アルコキシ基、トリフルオロメチル基、
二1・四基またはメチジ/ジオキシ基を表わす) で示される化合物またはそのヒドロキシ基における反応
性誘導体を反応させることを特徴とする一般式、 (但しX 、 Y 、 Z 、 L 、 Illは前記
と同じ意味を有する) で示されるピペラジン誘導体ま、たはその塩の製造法。
(1) A compound represented by the general formula (wherein, , halogen atom, lower alkyl group, lower alkoxy group, trifluoromethyl group,
21.4 group or methidi/dioxy group) or its reactive derivative at the hydroxy group (wherein X, Y, Z, L, Ill are as above) (having the same meaning) or a method for producing a piperazine derivative or a salt thereof.
(2)一般式 (但し、Wはハロゲン原子を、Xは)・ロゲ/原子を、
tは1から4の整数を表わす) で示される化合物に一般式、 (但し、mは1から4の整数を表わす)で示される化合
物を反応させて一般式、(但じX、t、mは前記と同じ
意味を有する)で示さノしる化合物となし、次いでこの
生成物またはそのヒドロキシ基における反応性誘導体に
一般式、 (但し、YおよびZは水素原子、ハロゲン原子、低級ア
ルキル基、低級アルコキシ基、トリフルオロメチル基、
ニトロ基苔たはメチレンジオキー シ基を表わす) で示される化合物寸たはそのヒドロキシ基における反応
性誘導体を反応させることを特徴とする一般式 (但し、X 、 Y 、 Z 、 L 、 mは前記と
同じ意味を有する) で示されるピペラジン誘導体またはその塩の製造法。
(2) General formula (where W is a halogen atom, X is a halogen atom), Rogge/atom,
t represents an integer from 1 to 4) A compound represented by the general formula, (where m represents an integer from 1 to 4) is reacted with the compound represented by the general formula, (where X, t, m has the same meaning as above), and then this product or its reactive derivative at the hydroxy group has the general formula, (However, Y and Z are hydrogen atoms, halogen atoms, lower alkyl groups, lower alkoxy group, trifluoromethyl group,
(representing a nitro group or a methylene dioxy group) or a reactive derivative of its hydroxy group (wherein X, Y, Z, L, m are (having the same meaning as above) A method for producing a piperazine derivative or a salt thereof.
JP58133398A 1983-07-21 1983-07-21 Preparation of piperazine derivative Pending JPS6025985A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP58133398A JPS6025985A (en) 1983-07-21 1983-07-21 Preparation of piperazine derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58133398A JPS6025985A (en) 1983-07-21 1983-07-21 Preparation of piperazine derivative

Publications (1)

Publication Number Publication Date
JPS6025985A true JPS6025985A (en) 1985-02-08

Family

ID=15103812

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58133398A Pending JPS6025985A (en) 1983-07-21 1983-07-21 Preparation of piperazine derivative

Country Status (1)

Country Link
JP (1) JPS6025985A (en)

Similar Documents

Publication Publication Date Title
JPH0687800A (en) Phenylalkoxy derivative
JPS626703B2 (en)
EP0139584A2 (en) Imidazoline derivatives, their preparation and therapeutical use
EP0008645A1 (en) Alkoxyphenylpyrrolidones, process for their preparation and medicaments containing them
JPS6025985A (en) Preparation of piperazine derivative
JP2001521498A (en) Method for producing O- (3-amino-2-hydroxy-propyl) -hydroxymic acid halide
CN111978264B (en) Industrial production method of deferasirox
US5932767A (en) Process for preparing dibenzocycloheptene compounds
JP2001158774A (en) Method for producing 6-trifluoromethylnicotinic acids
JPH02255673A (en) 4-aryloxy-1,3-benzodioxoles and production thereof
JPH04270272A (en) Production of aminoalkylmorpholine derivative
JP2003517029A (en) Method for producing trifluoromethylacetophenone
JP2672939B2 (en) Process for producing N-allyl-2,5-dimethyl-piperidinol-4-benzoyl ester
US3108110A (en) 1-[nu-lower alkyl-piperidyl-(4')]-3-phenyl-4-(parasubstituted benzyl)-pyrazolones
CA1069524A (en) Preparation of phenylalkanoylamines
JPS63211264A (en) Production of indolines
JP2554603B2 (en) Process for producing optically active 4- (2-methylpropyl) -5-phenyl-1,3-oxazolidin-2-one
JP2021104982A (en) Naftopidil monohydrochloride dihydrate and use thereof for preparation of naftopidil
JPH0150219B2 (en)
JPH0827109A (en) Manufacture of beta-(benzyl)indole-3-ethanol
JPH0317075A (en) Preparation of 6-fluorochromone-2-carboxylic acid derivative
JPS6033392B2 (en) 1,2-benzodiazepine derivative and method for producing the same
JP2001089449A (en) Production of 4,7-dioxo-5-azaspiro[2,4]heptane derivative
JPS58118566A (en) Novel heterocyclic acetic acid derivative and manufacture
JPS596306B2 (en) New method for producing N-substituted triazolone derivatives